0001611793-24-000002.txt : 20240916 0001611793-24-000002.hdr.sgml : 20240916 20240916133919 ACCESSION NUMBER: 0001611793-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240916 DATE AS OF CHANGE: 20240916 EFFECTIVENESS DATE: 20240916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONL Therapeutics, Inc. CENTRAL INDEX KEY: 0001611793 ORGANIZATION NAME: IRS NUMBER: 464627845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-524116 FILM NUMBER: 241300655 BUSINESS ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 BUSINESS PHONE: 734-926-5530 MAIL ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 D 1 primary_doc.xml X0708 D LIVE 0001611793 ONL Therapeutics, Inc. 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 (734) 412-8787 DELAWARE None None Corporation true David Esposito 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Executive Officer Director Marian Nakada 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director Aaron Fletcher 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director Michal Silverberg 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director Bill Burns 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director David Zacks 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Executive Officer Constance Chang 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Executive Officer Biotechnology Decline to Disclose 06b false 2024-09-12 false true false 0 65000002 59999998 5000004 false 35 0 0 0 false ONL Therapeutics, Inc. David Esposito David Esposito CEO & President 2024-09-16